top of page

Free Biopharma Daily Stock Updates - 04/15/22

  • Writer: BPIQ
    BPIQ
  • Apr 15, 2022
  • 1 min read

$XBI $87.77

BiopharmIQ offers pro members full access to FDA Catalyst Calendar, PDUFA's, Biotech Stock Ideas.

Pipeline Updates

$TGTX TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL.


$ANVS Annovis Bio Announces Publication of ANVS401 Mechanism of Action in Peer-Reviewed Pharmaceutics.


$BHVN BIOHAVEN REAL-WORLD STUDY HIGHLIGHTS INCREASED HEALTHCARE UTILIZATION AMONG AMERICANS WITH EPISODIC MIGRAINE HAVING HIGHER LEVELS OF MIGRAINE-RELATED DISABILITY.


Business Updates

$IMRA On April 12, 2022, the Board of Directors of IMARA Inc. approved a reduction of the Company’s workforce by approximately 83% across all areas of the Company, to a total of six remaining full-time employees.

Posted by DV/FS

 
 
 

Comments

bottom of page